Home › Chronic Subdural Hematoma › Massachusetts
Chronic Subdural Hematoma clinical trials in Massachusetts
3 studies for Chronic Subdural Hematoma are looking for participants at sites in Massachusetts.
Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center (BIDMC)/Harvard Medical School, Boston
- Lahey Hospital and Medical Center, Burlington
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT06181994Assessing Outcomes of Coil Embolization for Unilateral vs Bilateral Chronic Subdural Hematomas
- Lahey Hospital & Medical Center, Burlington
Recruiting
Ages 18 and older · All sexes · Updated Jul 20, 2026 · NCT07715656Chronic Subdural Hematoma Treatment With Embolization Versus Surgery Study
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
Recruiting
Ages 40 to 90 · All sexes · Updated May 22, 2026 · NCT06347796From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.